Serum Inorganic Phosphorus Concentrations Research Articles

Clinical Impact of Cytokine Release Syndrome on Prolonged Hematotoxicity after Chimeric Antigen Receptor T Cell Therapy: KyoTox A-Score, a Novel Prediction Model

Prolonged hematotoxicity is the most common long-term adverse event in chimeric antigen receptor T cell therapy (CAR-T). To evaluate the impact on prolonged cytopenia of inflammatory status after CAR T infusion, we performed a single-center retrospective study and analyzed patients with B cell lymphomas after CAR-T. Among 90 patients analyzed at 90 days after infusion, the cumulative incidence was 57.5% for prolonged neutropenia, 36.7% for anemia, and 49.8% for thrombocytopenia. Patients who experienced cytokine release syndrome (CRS) had significantly higher incidence and longer duration of prolonged cytopenia. In addition, we found that among patients with grade 1 CRS, those with a longer duration of CRS-related symptoms (>5 days; grade 1b in modified CRS grading [m-CRS]) had a significantly higher incidence and longer duration of prolonged cytopenia than those whose CRS-related symptoms resolved within 5 days (grade 1a m-CRS). Multivariate analysis revealed that a higher m-CRS grade (grade 1b or 2; hazard ratio [HR], 2.42), higher peak CRP (≥10 mg/dL; HR, 1.66), longer duration of elevated CRP (≥10 days; HR, 1.83), and a decrease in serum inorganic phosphorus concentration (≥30% from baseline; HR, 1.95) were associated with significantly higher cumulative incidence of prolonged neutropenia, as well as anemia and thrombocytopenia. Using these factors, we developed a new predictive scoring model for prolonged hematotoxicity, the KyoTox a-score, which can successfully stratify the incidence and duration of cytopenia independent of the existing model, CAR-HEMATOTOX, which is based on laboratory data at lymphodepletion. Thus, this newly developed post-CAR-T inflammation-dependent score is accurate and useful for predicting prolonged hematotoxicity.

Presence or severity of hypophosphatemia is not associated with survival outcome in postpartum downer dairy cows

To evaluate the association between serum phosphorus concentration and the outcome of postpartum downer cows. Postpartum downer dairy cows presented over a 22-year period. In this cross-sectional study (1994 to 2016), medical records of all postpartum downer cows presented to a referral large animal hospital were reviewed. The association between serum inorganic phosphorus concentration and survival was assessed using a multivariable logistic regression. 907 postpartum downer dairy cows were included and classified as hypophosphatemic (mild: > 2.25 to < 3.25 mg/dL, moderate: > 1.50 to ≤ 2.25 mg/dL, and severe: ≤ 1.50 mg/dL), normophosphatemic (≥ 3.25 and ≤ 8.76 mg/dL) or hyperphosphatemic (> 8.76 mg/dL). Hypophosphatemia was observed in 19.4% of the cows (n = 176). Of those, 54.5% (n = 96) were also hypocalcemic. Overall, 58.4% cows (n = 530) survived after hospitalization. Hypophosphatemia was not significantly associated with the outcome of postpartum downer cows (mild: OR = 1.0, 95% CI: 0.6 to 1.8; moderate: OR = 0.5, 95% CI: 0.2 to 1.1; severe: OR = 1.0, 95% CI: 0.4 to 2.4). Low serum phosphorus concentration was frequently observed with hypocalcemia and was not associated with the outcome of postpartum downer cows.

Acid-base imbalances and the association of blood-gas variables, electrolytes, and biochemical analytes with outcome in hospitalized calves undergoing abdominal surgery.

Surgical abdominal emergencies in calves are associated with a guarded prognosis and have the potential for complex metabolic derangements including acid-base imbalances. To perform a comprehensive analysis of acid-base status and to assess the prognostic relevance of preoperative clinicopathologic variables in calves undergoing abdominal surgery. Hospital-based study samples of 535 (dataset 1; DS1) and 83 calves (dataset 2; DS2). Retrospective (DS1) and prospective (DS2) case series. In DS1, acidemia (pH <7.33) was present in 49.9%, whereas alkalemia (pH >7.37) was present in 30.7% of calves. Plasma L-lactate, chloride, and serum inorganic phosphorus concentration accounted for 51.9%, 11.6% and 9.4% of the variation of venous blood pH, respectively. Classification tree analysis indicated that a negative outcome (death or euthanasia during hospitalization) was associated with venous pO2 ≤33.6 mm Hg, anion gap >18.3 and >22.9mEq/L, serum albumin concentration ≤36.5 and ≤29.4g/L, serum urea concentration >4.4 mmol/L, and plasma ionized calcium concentration ≤1.26 mmol/L. The area under the receiver operating characteristic curve of this model was 0.85 (95% CI: 0.82-0.89, P < .001) and the resulting sensitivity and specificity for the prediction of nonsurvival at the optimal probability cut-point of 0.5 was 89.8% and 65.7%, respectively. In DS2 the model had a similar sensitivity and specificity of 90.5% and 70%, respectively. Clinicopathologic imbalances and associated changes of acid-base status are common in calves with surgical abdominal emergencies and have clinical utility for the prediction of a negative postoperative outcome.

Deterioration of Phosphate Homeostasis Is a Trigger for Cardiac Afterload - Clinical Importance of Fibroblast Growth Factor 23 for Accelerated Aging.

Background: After the discovery of the Klotho gene, phosphate came into focus as a pathogenetic aging agent. Phosphate homeostasis is controlled by phosphate-regulating hormones: fibroblast growth factor 23 (FGF23), vitamin D3, and parathyroid hormone. This study investigated the relationship between the deterioration in phosphate homeostasis and arterial stiffness by measuring serum FGF23 concentrations. Methods and Results: The study subjects comprised 82 hospitalized patients (31 males, 51 females; mean [±SD] age 78.6±10.5 years). All patients underwent chest computed tomography, measurement of central blood pressure (BP), and blood chemistry tests. Arterial calcification and/or stiffness was evaluated using the Agatston calcification score (ACS) and pulse wave velocity (PWV). PWV was significantly correlated with age (t=23.47, P<0.0001), estimated glomerular filtration rate (eGFR; t=-4.40, P<0.0001), and ACS (t=4.36, P<0.0001). Serum FGF23 concentrations were significantly correlated with age (t=2.52, P=0.014), eGFR (t=-3.37, P<0.001), serum inorganic phosphorus concentrations (t=3.49, P<0.001), serum vitamin D3 concentrations (t=-4.57, P<0.001), ACS (t=2.30, P=0.025), augmentation pressure (t=2.48, P=0.015), central systolic BP (t=2.00, P=0.049), plasma B-type natriuretic peptide (BNP) concentrations (t=3.48, P<0.001), and PWV (t=2.99, P=0.004). PWV was positively related to augmentation pressure (t=4.09, P<0.001), central systolic BP (t=3.13, P=0.002), and plasma BNP concentrations (t=3.54, P<0.001). Conclusions: This study shows that the increase in serum FGF23 concentrations reflects deterioration of phosphate homeostasis and is an important predictor for arterial stiffness, which intensifies cardiac afterload.

The relationships between environmental parameters in livestock pen and physiological parameters of Holstein dairy cows.

There has been an increase in temperature and the incidence of extreme weather events, such as heat wave, due to global warming, which has promoted the incidence of livestock diseases. Therefore, it is important to examine the effect of changes in environmental parameters on livestock performance. The aim of this study was to examine the relationship between ambient environmental conditions in livestock pen and the physiological parameters of Holstein dairy cows. The results showed that there was a decrease in the red blood cell counts, hemoglobin concentrations, and mean corpuscular hemoglobin concentration of the cows with increasing pen temperature, wet bulb globe temperature (WBGT), and temperature humidity index (THI). Additionally, high daily variation in temperature caused a decrease in the serum albumin levels of the cows. Moreover, the lowest serum calcium, inorganic phosphorus, and magnesium concentrations were observed in November, and were negatively correlated with the 24-hr temperature, WBGT, and THI range of the pen prior to sampling. Multiple regression analysis showed a positive correlation between serum cortisol concentration and 24-hr WBGT range of the pen prior to samplings and packed cell volume. However, serum cortisol and total protein concentrations were negatively correlated. Overall, the findings of the study suggest that large variation in temperature induced stress in the cows, which could be overcome by increased water consumption and improved protein digestion and absorption by the animals, and the addition of minerals, such as calcium to the diet.

PREVALENCE AND RISK FACTORS OF SUBCLINICAL MILK FEVER AND KETOSIS IN LACTATING CROSS-BRED DAIRY COWS WITH THEIR THERAPEUTIC MANAGEMENT IN BANGLADESH

Background: Bovine Milk fever (MF/hypocalcaemia) and ketosis (CK/hypoglycemia and hyperketonemia) both in clinical and sub-clinical forms are the most important metabolic diseases caused by metabolic disorders of calcium and carbohydrate respectively that affect mainly high milk yielding dairy cows worldwide. Sub-clinical form may be more costly due to comparatively high prevalence and consequence of high risk of decreased productive and reproductive performances with increased reproductive and other disorders. Objectives: The objectives of this study were to determine the prevalence of sub-clinical hypocalcaemia (SCHC) and sub-clinical ketosis (SCK) and to investigate important potential risk factors for SCHC and SCK with their therapeutic management in lactating cross-bred dairy cows. Materials and Methods: A cross sectional study was conducted on 220 dairy crossbred (HF  L = 190, SH  L = 20 and JS  L = 10) cows maintained in nine dairy farms and one smallholder farm during the period from July to November 2016. The parity (1 to 8), lactation stages (1 to 13 weeks), body condition score (BCS), breed (3 crossbreds), age (3.5 to 14 years) and milk yield (liter/day) were evaluated as possible risk factors. The serum calcium, inorganic phosphorus, magnesium and glucose concentrations of the 220 dairy cows were determined by using imported commercial kits. Dairy cows with serum calcium concentrations  8.0 mg/dl and serum glucose  44.0 mg / dl with positive ketone tests but not showing any clinical signs were considered SCHC and SCK respectively. Results: The overall prevalence of SCHC was 30.0%, of which 32.11% were recorded in HF  L, 15.0% in SH  L and 20.0% in JS  L cross-bred cows. The overall prevalence of SCK was 25.0%, of which 27.37% in HF  L, 10.0% in SH  L and 10.0% in JS  L cross-bred cows. The SCHC was recorded 10 times greater than MF and SCK 6 times greater than CK in Bangladesh. The hypocalcemia and hypophosphatemia with hypermagnesemia status were recorded in SCHC affected lactating cows which were more significantly (p &lt; 0.05) higher (46.67%) at 4th parity and lower (16.67%) at 1st parity. The significantly (p &lt; 0.01) higher prevalence of SCK was recorded at the 4th (53.33%) in comparison to other parity especially lowest at 1st (2.78%) and 2nd (4.0%) parity. The significantly (p &lt; 0.1) highest prevalence of SCHC and SCK were recorded at high milk yield during the 1st (94.44%; 77.78%) and 2nd (66.67%; 56.67%) weeks of lactation period than the higher lactation stages respectively. The effects of BCS on the milk yield and the prevalence of SCHC and SCK are presented and discussed. Encouraging results with increased blood calcium and glucose levels were obtained on the therapeutic response of SCHC with oral calcium and SCK with oral propylene glycol. Conclusions: The SCHC and SCK have detrimental effects on cow health, productivity and reproduction and also predisposes to other diseases and disorders. The efficient balanced ration, periodic screening blood, milk and urine for determination of concerned biochemical constituents and ketone bodies considering risk factors could help to early detection of SCHC and SCK to limit their effects in dairy cattle. The high prevalence of SCHC and SCK recorded in this study should be viewed as a potential health risk to the transition cows that requires further research. Keywords: Sub-clinical milk fever, Sub-clinical ketosis, crossbred cows, prevalence, risk factors, calcium, magnesium, phosphorus, glucose, ketone bodies, therapeutic management, Bangladesh

Osteomalacia and renal failure due to Fanconi syndrome caused by long-term low-dose Adefovir Dipivoxil: a case report

BackgroundProgressive bone pain and fracture and abnormal positron emission tomography combined with a computed tomography are main reasons for the oncologists suspecting bone tumor. During the patient’s medical treatment, the oncologists’ unfamiliarity with adverse reactions to anti-HBV drugs were main reason for the long-term exposure to the drug and the adverse reaction (ADR) experienced by the patient.Case presentationA 63-year-old Chinese man had a 27-month history of progressive generalized bone pain combined with spontaneous fractures. Positron emission tomography combined with a computed tomography, revealed an abnormal increase in ribose metabolism and low positron serum inorganic phosphorus concentration (0.7; 0.78–1.65 mmol/L). Serum creatinine level was 252 μmol/L (53–97) μmol/L, and glomerular filtration rate was 22.79 mL/min/1.73 m2. The patient was referred to a multidisciplinary clinic to clarify the diagnosis of myeloma or bone tumor for further treatment in 2017. His medical history revealed that he had a 30-year history of chronic hepatitis B infection. He had received lamivudine at a daily dose of 100 mg for 19 years (1990 to 2009), which had been changed to adefovir (10 mg/day) owing to lamivudine resistance in 2009. Based on the changes in the patient’s laboratory markers and the results of emission computed tomography and other radiographic findings, adefovir-induced hypophosphatemic osteomalacia due to acquired renal Fanconi syndrome was suspected by the clinical pharmacist. Considerable clinical improvement was observed after adefovir discontinuation and the administration of entecavir (1.0 mg, every other day).ConclusionFanconi syndrome with osteomalacia can develop in patients with chronic hepatitis B infection being treated with adefovir at a conventional low dosage of 10 mg/day. This case highlights the importance of ADR as a differential diagnosis and the need of pharmacists with drug safety expertise expert in the patient management.

Clinical and genetic analysis of idiopathic normophosphatemic tumoral calcinosis in 19 patients.

Tumoral calcinosis is a rare clinicopathological entity characterized by ectopic soft-tissue calcification, typically periarticular. Normophosphatemic tumoral calcinosis is seldom reported in East Asian populations, and the preoperative diagnosis is often elusive. This study was performed to characterize the clinical profile of normophosphatemic tumoral calcinosis and investigate the presence of the SAMD9 gene mutation. The clinical features, pathological examination findings, and outcomes of 19 subjects were retrospectively reviewed. All patients were analyzed for SAMD9 gene mutation using paraffin-embedded tumoral calcinosis specimens. Nineteen subjects were analyzed (7 males, 12 females). Their mean age at surgery, mean age at symptom onset, and median disease duration was 51.9 ± 17.3 (range 7-75)years, 49.1 ± 17.2 (range 7-74)years, and 1.3 (interquartile range 0.5-3.0)years, respectively. Lesions were located in the hand in 8 (42.1%) subjects; wrist in 5 (26.3%); shoulder in 2 (10.5%); and hip, knee, buttock, and scrotum in 1 (5.3%) subject each. The lesions in 17 (89.5%) subjects were located around the joints [small joints (hand and wrist) in 13 (68.4%) and large joints (shoulder, hip, and knee) in 4 (21.1%)]. Lesions occurred in the upper limbs in 15 (78.9%) subjects and in the lower limbs in 2 (10.5%). Multiple-lesion involvement (distal right index finger and middle finger) occurred in one (5.3%) subject. Symptoms included pain in 15 (78.9%) subjects, impaired mobility in 5 (26.3%), swelling in 5 (26.3%), numbness in 2 (10.5%), and an asymptomatic mass in 2 (10.5%). The serum inorganic phosphorus concentration was normal in all 19 subjects (mean 1.17 ± 0.15mmol/L). The serum calcium concentration was normal in 18 subjects and low in 1. The serum alkaline phosphatase concentration was normal in all 19 subjects. Pathological examination indicated multiple nodules of calcified materials that manifested an amorphous or granular blue-purple crystal and were surrounded by proliferation of mononuclear or multinuclear macrophages, osteoclastic-like giant cells, fibroblasts, and chronic inflammatory cells. Notably, different phases of pathological manifestations were observed in the same microscopic field. During follow-up (0.5-65.0months), no recurrence of tumoral calcinosis was observed in 18 (94.7%) subjects, but 1 subject developed in situ recurrence of an asymptomatic subcutaneous mass after 6months postoperatively. Genetic analysis in all 19 subjects revealed no SAMD9 gene mutations. Most subjects were females and developed calcinosis in adulthood. Small joints (hand and wrist) and the upper limbs were frequently involved. The presence of different phases of pathological features in the same subject suggests that about half of the study participants had been misdiagnosed with another condition (such as gout, osteoarthritis, etc.). Complete surgical excision led to cure without recurrence during follow-up in majority of the study participants.

Evaluation of nephrotoxicity and ototoxicity of aminosidine (paromomycin)-allopurinol combination in dogs with leishmaniosis due to Leishmania infantum: A randomized, blinded, controlled study

Canine leishmaniosis due to Leishmania infantum is a widespread zoonotic disease. Although aminosidine can be an effective treatment, current therapeutic recommendations do not advocate its use, mainly due to concerns regarding the potential nephrotoxicity and ototoxicity of this drug. The aim of this randomized, blinded, controlled study was to evaluate the nephrotoxicity and ototoxicity of aminosidine-allopurinol combination and compare it with that of meglumine antimonate-allopurinol combination in non-azotemic dogs with leishmaniosis. Forty dogs with leishmaniosis were randomly assigned to be treated with either aminosidine at 15 mg/kg, subcutaneously, once daily for 28 days (group A) or with meglumine antimonate at 100 mg/kg, subcutaneously, once daily for 28 days (group B). In addition to either drug, dogs in both groups were administered allopurinol at 10 mg/kg per os twice daily for 2 months. Kidney function was evaluated through measurement of serum creatinine, urea nitrogen, inorganic phosphorus, and cystatin-c concentrations and complete urinalysis, including protein-to-creatinine ratio, at baseline and after 14, 28, and 60 days from the beginning of the treatment. At the same time points, vestibular and auditory functions were evaluated through neurological examination and brainstem auditory evoked response (BAER) recordings of wave I, wave V, inter-wave I–V latencies, and minimum hearing thresholds. None of the dogs developed clinicopathological evidence of kidney disease during the study. Serum creatinine concentration increased >0.3 mg/dl over baseline in 2 dogs in group A and in 5 dogs in group B. Parameters of kidney function were not significantly different or were improved compared to baseline and the only difference between the two groups was the lower concentration of serum creatinine in group A. None of the dogs developed peripheral vestibular syndrome or hearing impairment. At the end of the study, parameters of auditory function were not significantly different or were improved compared to baseline and there were no differences between the two groups. The results of this study show that the nephrotoxicity and ototoxicity of aminosidine, when administered to non-azotemic dogs with leishmaniosis at 15 mg/kg subcutaneously once daily for 28 days along with allopurinol, is minimal and does not differ from that of meglumine antimonate.

Relationship between the level of estrogen, calcium and phosphorus concentration in serum with benign paroxysmal positional vertigo

Objective:To investigate relationship between the level of estrogen, calcium and phosphorus concentration in serum with benign paroxysmal positional vertigo(BPPV). Method:A total of 84 patients with idiopathic BPPV were enrolled in the experimental group, including 32 non-menopausal women, 24 menopausal women, and 28 males; 83 healthy people without vertigo and vestibular disease were selected as the control group consisted with 32 non-menopausal women, 24 menopausal women and 27 males. The levels of estradiol, serum calcium and serum inorganic phosphorus were measured in all participants. The difference of estrogen level, serum calcium and serum inorganic phosphorus concentration between the experimental group and the control group was analyzed by t test. Result:The total number, age distribution and gender composition of the experimental group and the control group were basically paired, and the age difference was not statistically significant (P=0.71). The overall estrogen level in the experimental group was lower than that in the control group (P<0.01). Among them, the female group's estrogen level, menopausal female estrogen level and male estrogen level in the experimental group were lower than the control group (P<0.01); there was no significant difference in serum calcium and serum inorganic phosphorus concentration between the experimental group and the control group (P=0.55, 0.11, respectively). Conclusion:The decrease of estrogen level may be a risk factor for idiopathic BPPV. The relationship between serum calcium and serum inorganic phosphorus concentration and BPPV needs further study.

Effects of Feeding Graded Levels of Distillers Dried Grains with Soluble DDGS) With or Without Supplementation of Multi-enzymes on Blood Bio-Chemical Constituents of Indigenous Chicken

An experiment was conducted using distillers dried grains with soluble (DDGS) at 0, 10 and 20% levels with or without enzymes supplementation in the diets of indigenous chicken to study the effect on different blood bio-chemicals parameters. A total of one hundred and eighty (21 days old) indigenous chicks were divided into six groups viz. T1, T2, T3, T4, T5 and T6 containing 30 chicks in each group. The birds of T1 (control) and T2 groups were offered the standard chick, grower and layer feeds as per BIS, 2007 without and with multi-enzymes (Xzyme), respectively. The birds of T3, T4, T5 and T6 groups were fed the rations containing 10% DDGS without and with enzymes and 20% DDGS without and with enzymes, respectively. The feeding trial was conducted for a period of 13 fortnights. The average levels of different blood parameters, estimated at the end of the experiment, viz. haemoglobin, glucose, serum protein, lipid, cholesterol, aspartate aminotransferase (AST), alanine aminotransferase (ALT), calcium and phosphorus ranged from 9.96±0.20 to 10.91±0.24 g/dl, 185.08±0.54 to 188.67±1.86 mg/dl, 3.05±0.17 to 3.32±0.09 g/dl, 72.45±0.29 to 72.96±0.49 mg/dl, 130.91±0.59 to 133.71±2.07 mg/dl, 71.66±0.44 to 72.28±0.40 U/L, 11.42±0.32 to 11.93±0.12 U/L, 10.16±0.44 to 10.81±0.29 mg/dl and 4.93±0.11 to 5.94±0.14 mg/dl, respectively. Non-significant (P>0.05) differences were observed with respect to average values of different blood parameters among the treatment groups except for blood inorganic phosphorus. Serum concentration of inorganic phosphorus was significantly (P<0.05) lower in T1 as compared to other groups. It can be concluded that the incorporation of DDGS up to 20% level in the diets of indigenous chicken did not have any adverse effect on the blood bio-chemical constituents of experimental birds.

Effect of long-term administration of ranitidine, a histamine H2 receptor antagonist, on bone metabolism in young growing rats.

Histamine regulates function of osteoclasts and osteoblasts, however data regarding the influence of histamine H2 receptors antagonists on bone tissue are ambiguous. Factors that influence growing skeleton may have an important impact on the peak bone mass and future risk of fractures. The aim of our study was the assessment of influence of ranitidine, on growing bones. The experiment was carried out on young male Wistar rats divided into two groups receiving either ranitidine (10mg/kg ip) or vehicle. A significant decrease in femoral BMD in ranitidine-treated rats (R) compared to vehicle-treated ones (C) was detected (0.262±0.009g/cm2vs. 0.271 ±0.007g/cm2, p<0.05). In group R we observed elevated serum C-terminated telopeptide of type I collagen (CTX) level with concomitantly lowered serum osteocalcin (OC) concentration comparing to control group (151.2±27.2pg/ml vs. 101.5±55.6, p<0.05 and 229.1±50.0pg/ml vs. 292.0±52.9, p<0.05, respectively). Serum concentration of inorganic phosphorus was lower in group R than in group C (134±13mmol/L vs. 157±28mmol/L, p<0.05). Long-term administration of ranitidine increases bone resorption and decreases bone formation in growing rats leading to decrease in BMD.

Influence of proton pump inhibitors and histamine H2 receptor antagonists on serum phosphorus level control by calcium carbonate in patients undergoing hemodialysis: a retrospective medical chart review.

BackgroundHyperphosphatemia is one of the common complications in patients undergoing hemodialysis. Although calcium carbonate (CaC) is often used to control serum inorganic phosphorus level in dialysis patients, co-administration of gastric acid reducers (ARs) may interfere with the phosphate binding effect of CaC. We performed a retrospective medical chart review to study whether ARs attenuate the hypophosphatemic effect of CaC in patients undergoing hemodialysis.MethodsOne hundred and eight chronic hemodialysis patients receiving either CaC alone or CaC concomitant with one of the ARs (proton pump inhibitors and histamine H2-receptor antagonists) were retrieved from the medical charts in Juntendo University Nerima Hospital. The patients were subdivided according to the interval between hemodialysis sessions (interdialysis interval of 48 or 72 h). A multivariate analysis was performed to identify clinical covariates associated with the variability of serum inorganic phosphorus levels. The study protocol was approved by the Institutional Review Board before the study was begun.ResultsAmong patients on hemodialysis with a 72-h interdialysis interval, the magnitude of increase in serum inorganic phosphorus concentration in patients receiving CaC and AR was significantly greater than in those receiving CaC alone. While a similar trend was observed among patients with a 48-h interdialysis interval, the difference did not reach a significant level. A multivariate regression analysis revealed that concomitant administration of ARs with CaC and a longer interdialysis interval (72 h) were significantly and independently associated with the magnitude of increase in serum phosphorus concentration between dialysis sessions. No significant differences in albumin-corrected serum calcium concentrations and incidence of pathological fractures were observed between patients receiving CaC alone and those receiving CaC with ARs.ConclusionsConcomitant use of ARs with CaC may attenuate the hypophosphatemic effect of CaC in patients undergoing chronic hemodialysis. When hemodialysis patients require prescription of ARs for the prevention of upper gastrointestinal mucosal diseases (such as peptic ulcer), it may be prudent to choose a phosphate binder other than CaC.

Vitamin B₁₂ deficiency-induced increase of osteoclastic bone resorption caused by abnormal renal resorption of inorganic phosphorus via Napi2a.

Vitamin B12 deficiency is a risk factor for bone disorders via mechanisms not fully understood. In this study, an increase in serum inorganic phosphorus (Pi) concentrations was associated with a vitamin B12 deficiency. Napi2a, a renal cotransporter for Pi reabsorption, accumulated on plasma membranes in a vitamin B12 deficiency suggests that vitamin B12 plays an important role in Pi homeostasis.

Fibroblast growth factor-23 and phosphorus related factors in young Japanese women: a cross-sectional study.

Phosphorus homeostasis is determined by dietary intake, intestinal absorption, and renal tubular reabsorption of phosphorus. Serum fibroblast growth factor-23 (FGF-23) is considered to be a sensitive early biomarker of disordered phosphorus metabolism in both patients with chronic kidney diseases and healthy subjects. However, the number of studies evaluating serum FGF-23 concentrations in healthy subjects is limited. The objective of this cross-sectional study was to examine the relationship between serum FGF-23 concentrations and phosphorus related factors in 182 young Japanese women (mean age, 19.5±0.4 years). We found that higher serum concentrations of inorganic phosphorus and lower serum concentrations of 1,25-dihydroxy vitamin D as well as lower fat but higher phosphorus and calcium intake were weakly but significantly associated with high serum concentrations of FGF-23, adjusted for postmenarcheal age and body weight. These results suggested that in young Japanese women, serum FGF-23 might be indicative of phosphorus nutrition status. However, it is worthy of note that maturity factors, including postmenarcheal age and physical attributes, such as body weight, might be related to serum FGF-23 concentrations.

English

The present study was carried out with the objective to know the calcium (Ca), inorganic phosphorus (P), magnesium (Mg), copper (Cu), iron (Fe) and zinc (Zn) concentrations in serum of repeat breeder and normal cyclic buffaloes during oestrus. On the day of estrus, blood samples were collected from 35 buffaloes with a history of repeat breeding (RB) and 35 normal cycling (NC) buffaloes for mineral estimation. In the second part of the study, 35 repeat breeder (RBS) buffaloes were treated with a mineral mixture given orally for 10 days at the dosage rate of 150 g per day whereas other 35 repeat breeder buffaloes were given no mineral mixture (RBC). The overall pregnancy rate as well as 1st, 2nd and 3rd service pregnancy rate was calculated. The serum calcium, inorganic phosphorus, magnesium, copper, iron and zinc concentrations were significantly lower (P < 0.01) in RB buffaloes as compared to NC buffaloes. Sodium concentrations differed non-significantly between repeat breeder and normal cyclic buffaloes. Repeat breeder buffaloes (RBS) when fed orally 150 g per day of the mineral mixture for 10 days, the 1st, 2nd and 3rd service pregnancy rates were 42, 25 and 20%, while, overall pregnancy rate in these animals was 87%; whereas in repeat breeder control buffaloes, the overall pregnancy rate was 21%. In conclusion, the concentrations of macro and micro minerals were significantly lower in repeat breeder buffaloes and mineral mixtures should be added in the food stuff to improve reproductive efficiency of repeat breeder buffaloes. Keywords: Buffalo, repeat breeder, minerals, pregnancy rate African Journal of Biotechnology , Vol. 13(10), pp. 1143-1146, 5 March, 2014

Biochemical Alterations of Experimentally Induced Hypomagnesaemia in Male Baladi Goats

This study was performed to investigate the effect of experimental hypomagnesemia on glutathione redox cycle, nitric oxide, serum, glucose, calcium, inorganic phosphorus, magnesium, cortisone and insulin in baladi goats. Two groups of twelve healthy Baladi male goats were used; the first one contained 5 animals and kept as control group. The second group includes 7 animals administrated with potassium chloride and citric acid daily until the development of the characteristic signs of hypomagnesaemia observed. Blood samples were collected at 6, 12, 18 and 24 days of administration. The obtained results revealed that decreases in serum magnesium, calcium, inorganic phosphorus, insulin and nitrate concentration and erythrocytes glutathione peroxidase, reduced glutathione, glutathione reductase, glutathione-S-transferase and total superoxide dismutase activities were decreased whereas erythrocytes catalase activity, serum cortisone and glucose concentration were significantly increased in hypomagnesemic induced group when compared with the control group. From these results it could be conclude that nitric oxide release, glutathione redox cycle activities, insulin and cortisone levels were markedly affected by hypomagnesaemia. Such alterations may be considered as predisposing factors responsible for the tissue injury and vascular changes observed in hypomagnesaemia.

The Bone Fracture–Healing Potential of Ormocarpum cochinchinense, Methanolic Extract on Albino Wistar Rats

Ormocarpum cochinchinense has been traditionally used for curing bone fracture in the villages of Tamil Nadu, India. Significant healing of bone fractures was observed in experiments with the albino Wistar rats. Animals treated orally as well as topically showed healing effects within 7 days by radiological examination and those treated topically alone had lower healing effects. Biochemical analysis of minerals and enzymes associated with bone healing showed a positive trend with serum Ca, inorganic phosphorus, and alkaline phosphatase concentrations in animals treated orally and topically. The concentration of Ca was reduced on the seventh day and increased on the fourteenth and twenty-first days.

New clinical trials with vitamin D and analogs in renal disease

Two new clinical trials highlight refinements in the use of vitamin D and its analogs in the treatment of secondary hyperparathyroidism in end-stage renal disease (ESRD), and the treatment of proteinuria in diabetics. In patients with ESRD, alfacalcidol is as effective as paricalcitol in suppressing parathyroid hormone; the occurrence of hypercalcemia and hyperphosphatemia is infrequent and similar with the two analogs. Oral cholecalciferol reduces albuminuria and urinary transforming growth factor-β1 in patients with type 2 diabetes mellitus and proteinuria.

사료내 Aspergillus niger 유래 복합효소의 첨가가 포유모돈의 생산성, 유생산, 혈액성상 및 분배설량에 미치는 영향

This study was conducted to investigate the effects of Aspergillus niger-derived multi-enzyme complex supplementation to feed- restricted lactating sows on performances, milk yield, blood profiles, and manure excretion as compared with ad libitum-fed sows without supplementation of enzyme. Fifty multiparous lactating Berkshire sows were allotted to 5 treatments of 10 sows per treatment during a 28-d lactation period and litter per sow was standardized to 9 suckling piglets. Treatments were ad libitum-fed sows without enzyme and feed-restricted sows supplemented with four increasing levels (0, 0.02, 0.04 and 0.08%) of multi-enzyme complex derived from Aspergillus niger. Blood samples from all sows were collected to determine serum metabolite concentrations before the morning feeding on d 27 of lactation. Litter body weight and a piglet weight at weaning, and litter weight gain significantly (P 0.05) to less decrease with increasing levels of enzyme complex. Serum inorganic phosphorus and non-esterified fatty acid concentrations significantly (P<0.05) increased with increasing levels of enzyme complex. Daily milk yield was not significantly different across treatments, but milk fat yield significantly (P<0.05) increased as multi-enzyme complex level increased. Manure output was significantly (P<0.01) higher for ad libitum-fed sows than for feed-restricted sows, but there was no significant difference among feed-restricted sows supplemented with increasing levels of multi-enzyme complex. Fecal phosphorus amount significantly (P<0.05) decreased with increasing levels of multi-enzyme complex. Feed costs of sows per litter weight gain were reduced by 1.25% to 9.67% with increasing levels of multi-enzyme complex as compared with ad libitum-fed sows without enzyme. The results indicated that multi-enzyme supplementation to feed-restricted lactating sows not only increased litter performances, but also was comparable to ad libitum-fed sows, resulting in reduced feed costs. Moreover, the reduction of fecal phosphorus amount with increasing levels of enzyme complex would contribute to the reduction of environmental pollution. (Key words : Lactating sows, Multi-enzyme complex, Litter weight gain, Milk fat yield, Fecal phosphorus)